Publications by authors named "Michael F Addo"

Claim this Profile
N
Novel indolylindazolylmaleimides as inhibitors of protein kinase C-beta: synthesis, biological activity, and cardiovascular safety.
Han-Cheng Zhang, Claudia K Derian, David F McComsey, Kimberly B White, Hong Ye, Michael F Addo

J Med Chem· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3.
Han-Cheng Zhang, Hong Ye, Bruce R Conway, Claudia K Derian, Michael F Addo

Bioorg Med Chem Lett· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3.
Han-Cheng Zhang, Kimberly B White, Hong Ye, David F McComsey, Claudia K Derian, Michael F Addo

Bioorg Med Chem Lett· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-affinity thrombin receptor (PAR-1) ligands: a new generation of indole-based peptide mimetic antagonists with a basic amine at the C-terminus.
Han Cheng Zhang, Kimberly B White, David F McComsey, Michael F Addo, Patricia Andrade-Gordon

Bioorg Med Chem Lett· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates.
Claudia K Derian, Bruce P Damiano, Michael F Addo, Andrew L Darrow, Michael R D'Andrea

J Pharmacol Exp Ther· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis